Associate Professor Marie Pettit
Marie has a background as a molecular biologist before beginning her career as a formulation scientist in 2013. Marie is the manager of Medway Centre for Pharmaceutical Sciences and has secured > £3.5 million from four large pharmaceutical companies. Marie is an internationally recognised expert in pre-formulation and formulation science. She has successfully developed formulations of novel API’s and taken them from discovery to development within her time managing the group. Areas that Marie has expertise in are pre-formulation science, analytical chemistry, formulation of actives for parental, oral, and inhaled delivery, stability indicating HPLC methodology and forced degradation studies. Her research interests are formulation and analysis of actives for dry powder inhalers using next generation impaction and the formulation of long acting injectables for neglected diseases.
Professor Steve Wicks
Steve is an emeritus professor of pharmaceutical sciences in the Faculty of Engineering and Science. Prior to this he spent 25 years with Pfizer Inc. rising to become a Vice-President of Worldwide Pharmaceutical Sciences in the Pfizer Global Research and Development division and a member of the Pfizer UK Group Ltd board of directors.
Steve was responsible for the pharmaceutical development of several marketed Pfizer products across therapeutic areas (Maraviroc Tablets, DepoProvera Uniject, Genotropin MK VII Pen Injection System, Revatio Tablet and IV Injection, Slentrol, Cerenia) as well as strategic deployment of resources. He is the pharmaceutical science member of the Governing Assembly of the Royal Pharmaceutical Society, a registered pharmacist and an EU Qualified Person.
Professor Joshua Boateng
Professor Joshua Boateng obtained his Bachelor of Pharmacy degree from the Kwame Nkrumah University of Science and Technology (Ghana) in February 1999 (First Class Honours) and then pursued an MSc in Pharmaceutical Analysis programme at the University of Strathclyde under a DFID Commonwealth Scholarship, graduating in November 2000. He subsequently undertook PhD research in Pharmaceutical Sciences (Drug Delivery and Formulation) under a Pfizer-sponsored project at the University of Strathclyde, from 2001-05. Subsequently, he took up a postdoctoral position at the Nottingham Trent University as part of a WADA-sponsored consortium on investigating surrogate biomarkers for detecting gene doping in sports, using mass spectrometry based proteomic approaches (2005-07).
Professor Joshua Boateng still maintains active research interests in all the above areas and published extensively as well as presented at several conferences around the above themes. He joined the School of Science at the Çï¿ûÊÓƵ in August 2007 and is currently a Professor in Pharmaceutics and Drug Delivery and Associate Head of School - Research and Knowledge Exchange for the School of Science.
2023 associates
- Andrew Deacon PhD
- Meena Afzali PhD
- Monika Thummapudi MSc
- Waheeda Jaffar MSc